280 related articles for article (PubMed ID: 31244670)
21. Future prospects for implantable devices for atrial defibrillation.
Tse HF; Lau CP
Cardiol Clin; 2004 Feb; 22(1):87-100, ix. PubMed ID: 14994850
[TBL] [Abstract][Full Text] [Related]
22. Optogenetic manipulation of anatomical re-entry by light-guided generation of a reversible local conduction block.
Watanabe M; Feola I; Majumder R; Jangsangthong W; Teplenin AS; Ypey DL; Schalij MJ; Zeppenfeld K; de Vries AA; Pijnappels DA
Cardiovasc Res; 2017 Mar; 113(3):354-366. PubMed ID: 28395022
[TBL] [Abstract][Full Text] [Related]
23. Systemic gene transfer enables optogenetic pacing of mouse hearts.
Vogt CC; Bruegmann T; Malan D; Ottersbach A; Roell W; Fleischmann BK; Sasse P
Cardiovasc Res; 2015 May; 106(2):338-43. PubMed ID: 25587047
[TBL] [Abstract][Full Text] [Related]
24. Optical ventricular cardioversion by local optogenetic targeting and LED implantation in a cardiomyopathic rat model.
Nyns ECA; Jin T; Fontes MS; van den Heuvel T; Portero V; Ramsey C; Bart CI; Zeppenfeld K; Schalij MJ; van Brakel TJ; Ramkisoensing AA; Zhang G; Poelma RH; Ördög B; de Vries AAF; Pijnappels DA
Cardiovasc Res; 2022 Jul; 118(10):2293-2303. PubMed ID: 34528100
[TBL] [Abstract][Full Text] [Related]
25. Spot light on skeletal muscles: optogenetic stimulation to understand and restore skeletal muscle function.
van Bremen T; Send T; Sasse P; Bruegmann T
J Muscle Res Cell Motil; 2017 Aug; 38(3-4):331-337. PubMed ID: 28918572
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
[TBL] [Abstract][Full Text] [Related]
27. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of Using Adjunctive Optogenetic Technologies in Cardiomyocyte Phenotyping - from the Single Cell to the Whole Heart.
Bub G; Daniels MJ
Curr Pharm Biotechnol; 2020; 21(9):752-764. PubMed ID: 30961485
[TBL] [Abstract][Full Text] [Related]
29. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
Klein HU; Goldenberg I; Moss AJ
Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of atrial sensing via a free-floating single-pass defibrillation lead for dual-chamber defibrillators.
Schuchert A; Niehaus M; Binner L; Belke R; Meinertz T
J Interv Card Electrophysiol; 2003 Jun; 8(3):209-14. PubMed ID: 12815307
[TBL] [Abstract][Full Text] [Related]
31. New concepts in atrial defibrillation.
Ayers GM
J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():155-61. PubMed ID: 10590503
[TBL] [Abstract][Full Text] [Related]
32. Recent Progress of Development of Optogenetic Implantable Neural Probes.
Zhao H
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800085
[TBL] [Abstract][Full Text] [Related]
33. [Atrial defibrillator].
Jung W; Lüderitz B
Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
[TBL] [Abstract][Full Text] [Related]
34. [Atrial defibrillator].
Jung W; Lüderitz B
Herz; 1998 Jun; 23(4):251-9. PubMed ID: 9690112
[TBL] [Abstract][Full Text] [Related]
35. Localized Optogenetic Targeting of Rotors in Atrial Cardiomyocyte Monolayers.
Feola I; Volkers L; Majumder R; Teplenin A; Schalij MJ; Panfilov AV; de Vries AAF; Pijnappels DA
Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29097406
[TBL] [Abstract][Full Text] [Related]
36. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.
Bianconi L; Mennuni M; Lukic V; Castro A; Chieffi M; Santini M
J Am Coll Cardiol; 1996 Sep; 28(3):700-6. PubMed ID: 8772759
[TBL] [Abstract][Full Text] [Related]
37. Direct current application: easy induction of ventricular fibrillation for the determination of the defibrillation threshold in patients with implantable cardioverter defibrillators.
Weismüller P; Richter P; Binner L; Grossmann G; Hemmer W; Höher M; Kochs M; Hombach V
Pacing Clin Electrophysiol; 1992 Aug; 15(8):1137-43. PubMed ID: 1381081
[TBL] [Abstract][Full Text] [Related]
38. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
Bollmann A; Husser D; Cannom DS
Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
[TBL] [Abstract][Full Text] [Related]
39. Advances in Implantable Optogenetic Technology for Cardiovascular Research and Medicine.
Madrid MK; Brennan JA; Yin RT; Knight HS; Efimov IR
Front Physiol; 2021; 12():720190. PubMed ID: 34675815
[TBL] [Abstract][Full Text] [Related]
40. Follow the Light - From Low-Energy Defibrillation to Multi-Site Photostimulation.
Diaz-Maue L; Schwaerzle M; Ruther P; Luther S; Richter C
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():4832-4835. PubMed ID: 30441427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
